COMPASS Pathways CMPS 深 沪
已收盘 09-25 16:00:00 美东时间
13.06
-0.030
-0.23%
华盛通- 最 高13.45
- 今 开13.20
- 成交量 222.89万股
- 最 低 13.0301
- 昨 收 13.09
- 总市值 18.09亿
- 52周最高 15.87
- 市盈率 静 --
- 换手率 1.61%
- 52周最低 4.88
- 委 比 48.54%
- 总股本 1.38亿
- 历史最高 61.69
- 量 比 0.70
- 振 幅 3.21%
- 历史最低 2.25
- 每 手 1
- 风险率 3.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Compass Pathways To Participate In Psych Congress 2026 With New Educational Campaign Regarding Treatment-Resistant Depression
Congress taking place in New Orleans, LA, from September 14-19. The Company will debut Change the Tune in TRD, a new educational campaign for U.S. HCPs focused on TRD, and present new HEOR data examining the burden of TRD alongside encore presentations from its COMP360 psilocybin clinical developmen...
09-08 18:36
Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path
Compass Pathways Plc (($CMPS)) has held its Q2 earnings call. Read on for the m...
08-21 08:21
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
RBC Capital Maintains Outperform on Compass Pathways, Lowers Price Target to $21
RBC Capital analyst Leonid Timashev maintains Compass Pathways (NASDAQ:CMPS) with a Outperform and lowers the price target from $22 to $21.
08-07 01:12
COMPASS Pathways shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results.
COMPASS Pathways shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results.
08-06 01:38
COMPASS Pathways ADS GAAP EPS of -$1.88
COMPASS Pathways ADS press release (CMPS): 1H GAAP EPS of -$1.88. Cash and cash equivalents were $433.3 million as of June 30, 2026, compared with $149.6 million as of December 31, 2025. Debt was $50....
08-05 18:38
Compass Pathways Q2 EPS $(1.88) Misses $(0.37) Estimate
Compass Pathways (NASDAQ:CMPS) reported quarterly losses of $(1.88) per share which missed the analyst consensus estimate of $(0.37) by 408.11 percent. This is a 358.54 percent decrease over losses of $(0.41) per share from the same period last year.
08-05 18:33
Psilocybin shown to ease PTSD in veterans in small study
A pilot study involving US military veterans who were experiencing severe PTSD and were not helped by other therapies found that many of them saw relief when given psilocybin, the active ingredient in...
07-30 23:53
美股大行评级 | ITG、Bending Spoons获多家大行首予买入评级；瑞银下调微软目标价从510美元降至480美元
今日重点评级关注：BTIG：上调Outlook Therapeutics"买入"评级，目标价4美元；TD Cowen：维持Nakamoto"买入"评级，目标价从1美元升至17美元
07-28 11:34
Wells Fargo Initiates Coverage On Compass Pathways with Equal-Weight Rating, Announces Price Target of $13
Wells Fargo analyst Benjamin Burnett initiates coverage on Compass Pathways (NASDAQ:CMPS) with a Equal-Weight rating and announces Price Target of $13.
07-27 20:42
